Company Filing History:
Years Active: 2015
Title: Innovations in Hypertension Management: The Contributions of Inventor Chunhua Hao
Introduction: Chunhua Hao, an accomplished inventor based in Tianjin, China, has made significant strides in the field of pharmaceutical research. With a focus on developing innovative solutions for hypertension management, his work contributes to improved healthcare outcomes.
Latest Patents: Chunhua Hao holds a notable patent for a pharmaceutical composition comprising candesartan or its ester and chlorthalidone. This composition is characterized by a specific weight ratio of candesartan to chlorthalidone ranging from 5.3:1 to 1:6.25. The invention highlights a synergistic antihypertensive effect, demonstrating the potential to enhance and prolong the duration of antihypertensive action, offering new hope for hypertension patients.
Career Highlights: Hao's dedication to pharmaceutical research is most prominently showcased through his affiliation with the Tianjin Institute of Pharmaceutical Research. His commitment to innovation is reflected not only in his solitary work but also through his active engagement in collaborative research efforts.
Collaborations: At the Tianjin Institute of Pharmaceutical Research, Chunhua Hao collaborates with esteemed colleagues, including Lida Tang and Zhuanyou Zhao. Their teamwork fosters an environment of shared knowledge and innovation, propelling forward the research initiatives aimed at developing cutting-edge pharmaceutical solutions.
Conclusion: In summary, Chunhua Hao exemplifies the role of inventors in advancing medical science through innovative patent developments. His contributions to hypertension management through his patented pharmaceutical composition indicate a promising future for patients and the healthcare industry. With ongoing collaborations and a steadfast commitment to research, Hao's work continues to inspire innovation in the field.